Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Russell E Ware

Showing results (11-20 of 267) with videos related to

Pageof 27
Sort By:
Hematology. American Society of Hematology. Education Program|December 17, 2009
Advances in the use of hydroxyureaRussell E Ware, Banu Aygun
Pediatrics|September 19, 2019
Newborn Screening With Sickle Cell Point of Care: A Valuable Resource in Low-Income SettingsRussell E Ware, Isaac Odame
Blood|July 9, 2011
Thrombopoiesis: new ITP paradigm?Jenny M Despotovic, Russell E Ware
American Journal of Hematology|November 25, 2003
Malignancy in patients with sickle cell diseaseWilliam H Schultz, Russell E Ware
Current Opinion in Hematology|March 25, 2020
Effective use of hydroxyurea for sickle cell anemia in low-resource countriesAlexandra Power-Hays, Russell E Ware
Pediatric Blood & Cancer|May 9, 2012
The second century of sickle cell diseaseRussell E Ware, Brigitta U Mueller
Pediatric Clinics of North America|April 3, 2008
Pediatric hematology and pediatric oncologyMax J Coppes, Russell E Ware
Pediatric Clinics of North America|April 3, 2008
Hydroxyurea for children with sickle cell diseaseMatthew M Heeney, Russell E Ware
Pediatric Blood & Cancer|December 11, 2024
The Voxelotor Effect: Decreased Affinity for New Drugs for Sickle Cell Disease?Charles T Quinn, Russell E Ware
Blood|September 30, 2021
Increased oxygen affinity: to have and to holdCharles T Quinn, Russell E Ware
Pageof 27

Showing results (11-20 of 267) with videos related to

Sort By:
Pageof 27
Hematology. American Society of Hematology. Education Program|December 17, 2009
Advances in the use of hydroxyureaRussell E Ware, Banu Aygun
Pediatrics|September 19, 2019
Newborn Screening With Sickle Cell Point of Care: A Valuable Resource in Low-Income SettingsRussell E Ware, Isaac Odame
Blood|July 9, 2011
Thrombopoiesis: new ITP paradigm?Jenny M Despotovic, Russell E Ware
American Journal of Hematology|November 25, 2003
Malignancy in patients with sickle cell diseaseWilliam H Schultz, Russell E Ware
Current Opinion in Hematology|March 25, 2020
Effective use of hydroxyurea for sickle cell anemia in low-resource countriesAlexandra Power-Hays, Russell E Ware
Pediatric Blood & Cancer|May 9, 2012
The second century of sickle cell diseaseRussell E Ware, Brigitta U Mueller
Pediatric Clinics of North America|April 3, 2008
Pediatric hematology and pediatric oncologyMax J Coppes, Russell E Ware
Pediatric Clinics of North America|April 3, 2008
Hydroxyurea for children with sickle cell diseaseMatthew M Heeney, Russell E Ware
Pediatric Blood & Cancer|December 11, 2024
The Voxelotor Effect: Decreased Affinity for New Drugs for Sickle Cell Disease?Charles T Quinn, Russell E Ware
Blood|September 30, 2021
Increased oxygen affinity: to have and to holdCharles T Quinn, Russell E Ware
Pageof 27